NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/06/2026 14:36
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization147.45 mln
Float35.62 mln
Earnings Date05/12/2026
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
10.1
Highly suspicious
1-Year Forecast
15.50
Transformational upside
Relative Strength
33
/ 100
Underperforming
Debt / Equity
-0.21
Negative equity
Dividend Yield
0.00%
No dividend
Business Description
Agenus Inc. is a US-based biotechnology company focused on developing treatments that use the body's immune system to fight cancer and infectious diseases. Founded in 1994 and headquartered in Lexington, Massachusetts, the company has built a broad pipeline of experimental drugs, several of which are currently in clinical trials. Agenus works alongside major pharmaceutical partners including Bristol-Myers Squibb, Merck, Gilead Sciences, and Incyte Corporation to advance these treatments toward patients.
